Alalevonadifloxacin

CAS No. 2892364-59-7

Alalevonadifloxacin( —— )

Catalog No. M36008 CAS No. 2892364-59-7

Alalevonadifloxacin is a DNA gyrase and DNA topoisomerase inhibitor and a novel antibacterial compound of the quinolone class targeting MRSa.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 319 Get Quote
5MG 494 Get Quote
10MG 715 Get Quote
25MG 1067 Get Quote
50MG 1444 Get Quote
100MG 1908 Get Quote
500MG 3825 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Alalevonadifloxacin
  • Note
    Research use only, not for human use.
  • Brief Description
    Alalevonadifloxacin is a DNA gyrase and DNA topoisomerase inhibitor and a novel antibacterial compound of the quinolone class targeting MRSa.
  • Description
    Alalevonadifloxacin is a DNA gyrase and DNA topoisomerase inhibitor and a novel antibacterial compound of the quinolone class targeting MRSa. Alalevonadifloxacin is potentially useful in the treatment of bacterial Gram-positive, Gram-negative and anaerobic infections.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Topoisomerase
  • Recptor
    Topoisomerase | DNA gyrase | Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2892364-59-7
  • Formula Weight
    527.56
  • Molecular Formula
    C23H30FN3O8S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S(C)(=O)(=O)O.O=C1C=2C3=C(C(=C(F)C2)N4CCC(OC([C@H](C)N)=O)CC4)CC[C@@H](C)N3C=C1C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pegamotecan

    Pegamotecan (PEG-camptothecin) is a topoisomerase I (TOP1) inhibitor with anticancer activity, and it is used in the treatment of esophageal, non-small cell lung and pancreatic cancers.

  • Aclacinomycin A

    Aclacinomycin A (Aclarubicin) is a novel anthracycline antibiotic isolated from Streptomyces galilei with antitumor activity.

  • Zoliflodacin

    Zoliflodacin (ETX0914, AZD0914) is a new bacterial DNA gyrase/topoisomerase inhibitor. Zoliflodacin has potent in vitro antibacterial activity against Gram-positive and Gram-negative organisms, including S. aureus (MIC90: 0.25 μg/mL).